These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26474109)

  • 1. Sensitive MRI detection of internalized T1 contrast agents using magnetization transfer contrast.
    Delli Castelli D; Ferrauto G; Di Gregorio E; Terreno E; Aime S
    NMR Biomed; 2015 Dec; 28(12):1663-70. PubMed ID: 26474109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of U-87 Tumor Cells by RGD-Functionalized/Gd-Containing Giant Unilamellar Vesicles in Magnetization Transfer Contrast Magnetic Resonance Images.
    Ferrauto G; Tripepi M; Di Gregorio E; Bitonto V; Aime S; Delli Castelli D
    Invest Radiol; 2021 May; 56(5):301-312. PubMed ID: 33273375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
    Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasmall graphene oxide based T
    Zhang M; Liu X; Huang J; Wang L; Shen H; Luo Y; Li Z; Zhang H; Deng Z; Zhang Z
    Nanomedicine; 2018 Oct; 14(7):2475-2483. PubMed ID: 28552648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay of T1- and T2-relaxation on T1-weighted MRI of hMSCs induced by Gd-DOTA-peptides.
    Cao L; Li B; Yi P; Zhang H; Dai J; Tan B; Deng Z
    Biomaterials; 2014 Apr; 35(13):4168-74. PubMed ID: 24560458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
    McVicar N; Li AX; Meakin SO; Bartha R
    NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of paramagnetic agents by off-resonance rotating frame technique in the presence of magnetization transfer effect.
    Zhang H; Xie Y
    J Magn Reson; 2007 Feb; 184(2):275-91. PubMed ID: 17123851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-Labeled Aminoglycoside and Its Potential Application as a Bacteria-Targeting Magnetic Resonance Imaging Contrast Agent.
    Zhang L; Liu Y; Zhang Q; Li T; Yang M; Yao Q; Xie X; Hu HY
    Anal Chem; 2018 Feb; 90(3):1934-1940. PubMed ID: 29293308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of paraCEST agents using frequency labeled exchange transfer MRI.
    Lin CY; Yadav NN; Ratnakar J; Sherry AD; van Zijl PC
    Magn Reson Med; 2014 Jan; 71(1):286-93. PubMed ID: 23468384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
    Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
    Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles.
    Bianchi A; Lux F; Tillement O; Crémillieux Y
    Magn Reson Med; 2013 Nov; 70(5):1419-26. PubMed ID: 23233439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents.
    Courant T; Roullin VG; Cadiou C; Callewaert M; Andry MC; Portefaix C; Hoeffel C; de Goltstein MC; Port M; Laurent S; Elst LV; Muller R; Molinari M; Chuburu F
    Angew Chem Int Ed Engl; 2012 Sep; 51(36):9119-22. PubMed ID: 22865621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights on the relaxation of liposomes encapsulating paramagnetic Ln-based complexes.
    Mulas G; Ferrauto G; Dastrù W; Anedda R; Aime S; Terreno E
    Magn Reson Med; 2015 Aug; 74(2):468-73. PubMed ID: 25186276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.